| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |